Connect with us
nairametrics

Coronavirus

Covid-19: WHO to start widespread vaccination mid next year

WHO had disclosed that about 150 vaccines for COVID-19 were under development globally.

Published

on

WHO vaccinations, Novavax secures $1.6 billion funding for covid-19 vaccine production

The Chief Scientist of the World Health Organization (WHO), Soumya Swaminathan, has revealed that widespread vaccination for the coronavirus disease is expected to start by the middle of 2021.

The WHO chief expressed cautious optimism over the state of the research and development process in an interview.

In her statement she said, “We have now over 20 candidates in clinical studies. So we are hopeful that a couple of them will work. It would be very unlucky if all of them fail.”

Download the Nairametrics News App

“So if we are very practical, then we are looking at the middle of 2021 when we will have a vaccine that can be widely deployed. Of course it’s impossible to predict,” she added.

GTBank 728 x 90

Swaminath pointed out that the global race to develop a vaccine had been the fastest timeline ever seen, while noting that there were only 3 months between the time the virus’ genetic sequence was published in January and the time the first trial began.

There have been several global efforts at the development of potential vaccines for the coronavirus pandemic. The WHO had disclosed that about 150 vaccines for COVID-19 were under development globally.

READ ALSO: Uber’s acquisition of rival, Careem, raises anti-competition concerns

GTBank 728 x 90

The novel coronavirus, which was first detected in the Chinese city of Wuhan late last year, has since spread to almost every corner of the world, with more than 14 million people infected and over 600,000 casualties. The US currently leads the world in confirmed cases, with Brazil taking up the second position.

The pandemic’s epicenter has shifted from China to Europe and right now to the Americas, especially with the resurgence of the spread of the virus. This has led to renewed lockdowns and tough restrictions on public life and travel.

READ ALSO: IMF expects Nigeria’s GDP to shrink by 5.4% in 2020

Some places where the virus was brought under control are seeing an uptick in cases thereby increasing fears of a second wave of infections and a new round of restrictions.

Chike Olisah is a graduate of accountancy with over 15 years working experience in the financial service sector. He has worked in research and marketing departments of three top commercial banks. Chike is a senior member of the Nairametrics Editorial Team. You may contact him via his email- [email protected]

Click to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Coronavirus

COVID-19 Update in Nigeria

On the 28th of September 2020, 136 new confirmed cases and 3 deaths were recorded in Nigeria

Published

on

The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record increases as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 58,460 confirmed cases.

On the 28th of September 2020, 136 new confirmed cases and 3 deaths were recorded in Nigeria, having carried out a total daily test of 1,450 samples across the country.

To date, 58,460 cases have been confirmed, 49,895 cases have been discharged and 1,111 deaths have been recorded in 36 states and the Federal Capital Territory. A total of 507,006  tests have been carried out as of September 28th, 2020 compared to 505,556 tests a day earlier.

COVID-19 Case Updates- 28th September 2020,

  • Total Number of Cases – 58,460
  • Total Number Discharged – 49,895
  • Total Deaths – 1,111
  • Total Tests Carried out – 507,006

According to the NCDC, the 136 new cases were reported from 13 states- Lagos (71), Rivers (23), Plateau (12), Adamawa (6), Oyo (6), Kaduna (5), Abia (3), FCT (3), Katsina (2), Kwara (2), Bauchi (1), Borno (1), Edo (1).

Meanwhile, the latest numbers bring Lagos state total confirmed cases to 19,310, followed by Abuja (5,677), Plateau (3,400), Oyo (3,260), Edo (2,625), Kaduna (2,402), Rivers (2,370), Ogun (1,836), Delta (1,802), Kano (1,737), Ondo (1,631), Enugu (1,289), Ebonyi (1,040), Kwara (1,034), Abia (894), Gombe (864). Katsina (859), Osun (827),  Borno (742), and Bauchi (699).

GTBank 728 x 90

Imo State has recorded 568 cases, Benue (481), Nasarawa (449), Bayelsa (398),  Jigawa (325), Ekiti (321), Akwa Ibom (288), Niger (259), Adamawa (240), Anambra (237), Sokoto (162), Taraba (95), Kebbi (93), Cross River (87), Zamfara (78), Yobe (76), while Kogi state has recorded 5 cases only.

READ ALSO: COVID-19: Western diplomats warn of disease explosion, poor handling by government

Lock Down and Curfew

In a move to combat the spread of the pandemic disease, President Muhammadu Buhari directed the cessation of all movements in Lagos and the FCT for an initial period of 14 days, which took effect from 11 pm on Monday, 30th March 2020.

GTBank 728 x 90

The movement restriction, which was extended by another two-weeks period, has been partially put on hold with some businesses commencing operations from May 4. On April 27th, 2020, Nigeria’s President, Muhammadu Buhari declared an overnight curfew from 8 pm to 6 am across the country, as part of new measures to contain the spread of the COVID-19. This comes along with the phased and gradual easing of lockdown measures in FCT, Lagos, and Ogun States, which took effect from Saturday, 2nd May 2020, at 9 am.

On Monday, 29th June 2020 the federal government extended the second phase of the eased lockdown by 4 weeks and approved interstate movement outside curfew hours with effect from July 1, 2020. Also, on Monday 27th July 2020, the federal government extended the second phase of eased lockdown by an additional one week.

On Thursday, 6th August 2020 the federal government through the secretary to the Government of the Federation (SGF) and Chairman of the Presidential Task Force (PTF) on COVID-19 announced the extension of the second phase of eased lockdown by another four (4) weeks.

READ ALSO: Bill Gates says Trump’s WHO funding suspension is dangerous

Fidelity ads

 

 

Continue Reading

Coronavirus

Lagos launches N5 billion support fund for 2,000 low-cost private schools

The Governor said the facility will benefit low-cost schools with amounts ranging from N500,000 to N5 million.

Published

on

Lagos State government has launched a N5billion support fund to help reduce the impact of Coronavirus pandemic on low-cost private schools in the state.

This was disclosed by the Governor of the state, Babajide Sanwo-Olu via his Twitter handle on Friday.

READ: N4.16 billion unpaid lottery revenue recovered by EFCC

According to him, the educational sector is one of those severely impacted by the pandemic, with schools and vocational learning-centres shut since March.

He said, “With access to funding for privately owned schools and vocational training centres in the state, we are confident that this programme, under the partnership between First Bank Nigeria and Lagos State Education Trust Fund (LSETF) will help accelerate a sustainable return to learning and skills acquisition.”

GTBank 728 x 90

READ: FG releases new details on MSMEs support scheme, budgets N200 billion for loans

He explained that the facility will benefit 2,000 low-cost schools with amounts ranging from N500,000 to N5 million.

GTBank 728 x 90

Explore the Nairametrics Research Website for Economic and Financial Data

“As a responsible Government, we are obligated to provide interventions that would enable learners in schools study in line with the new normal,” the Governor Sanwo-Olu added.

The Chief Executive Officer, First Bank Nigeria, Dr Adesola Adeduntan, said “With this partnership, we are sure that registered educational institutions in Lagos State will have access to funds at subsidised interest rates to meet their needs as they reopen at this auspicious time.”

Continue Reading

Coronavirus

WHO endorses emergency use of China’s COVID-19 vaccine

China says WHO has approved the emergency use of its COVID-19 vaccine.

Published

on

WHO endorses emergency use of China’s Covid-19 vaccine

The World Health Organization (WHO) has endorsed the plans by China to start administering experimental coronavirus vaccines to people while clinical trials are still underway.

This disclosure was made by a Chinese Health Commission official, Zheng Zhongwei, during a news conference on Friday, September 25, 2020.

Zheng recalled that China launched its emergency programme in July, having communicated with the WHO in late June. Hundreds of thousands essential workers and other limited groups of people considered at high risk of infection have been given the vaccine, even though its efficacy and safety had not been fully established as Phase 3 clinical trials have not yet been completed.

Zheng at the news conference said, “At End-June, China’s State Council approved a plan of COVID-19 vaccine emergency use program. After the approval, on June 29, we made a communication with the relevant representatives of the WHO Office in China, and obtained support and understanding from WHO.’’

Nairametrics had reported that Chinese Pharmaceutical firms have been quite aggressive about the development of a Covid-19 vaccine with the likes of Sinovac Biotech and Sinopharm publicly displaying their vaccine candidate for the first time at a trade fair in Beijing earlier this month.

GTBank 728 x 90

(READ MORE: COVID-19: European regulator ready to approve first successful vaccine this year)

It was pointed out that China National Pharmaceutical Group (Sinopharm) and the US-listed Sinovac Biotech SVA.O, are developing the three vaccines under the state’s emergency use program just as a fourth COVID-19 vaccine is being developed by CanSino Biologics 6185 HK, was approved for use by the Chinese military in June.

The WHO chief scientist Soumya Swaminathan, while describing it as a temporary solution, said earlier this month in Geneva that national regulatory authorities could approve use of medical products within their own jurisdictions in the current emergency situation.

GTBank 728 x 90

He emphasized that the long-term solution in the successful development of a Covid-19 vaccine, lay in completion of Phase 3 trials, this is as China has not publicly released full details of its emergency use programme.

Zheng disclosed that China’s annual production capacity of COVID-19 vaccines is expected to reach 610 million doses by end-2020 and 1 billion doses by 2021. He said that the price of the vaccine will be affordable for the general public.

Continue Reading
Advertisement
Advertisement
Advertisement
ikeja electric
Advertisement
Advertisement
Patricia
Advertisement
FCMB ads
Advertisement
IZIKJON
Advertisement
Fidelity ads
Advertisement
first bank
Advertisement
bitad
Advertisement
deals book
Advertisement
financial calculator
Advertisement
deals book
Advertisement
app
Advertisement